Marko Kavčič

775 total citations
34 papers, 439 citations indexed

About

Marko Kavčič is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marko Kavčič has authored 34 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Hematology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marko Kavčič's work include Neutropenia and Cancer Infections (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Marko Kavčič is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Marko Kavčič collaborates with scholars based in United States, Slovenia and Canada. Marko Kavčič's co-authors include Richard Aplenc, Brian T. Fisher, Alix E. Seif, Yimei Li, Yuan‐Shung Huang, Kari Torp, Damian Walker, Rochelle Bagatell, Marijana Vujković and Janez Jazbec and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marko Kavčič

33 papers receiving 435 citations

Peers

Marko Kavčič
Seth J. Rotz United States
Kari Torp United States
George R. Buchanan United States
Ülker Koçak Türkiye
Luca Cupelli Italy
Makoto Tsujita Japan
Hor Ismail Poland
Rahul Naithani India
Domingo del Castillo Spain
Gökçen Örgül Türkiye
Seth J. Rotz United States
Marko Kavčič
Citations per year, relative to Marko Kavčič Marko Kavčič (= 1×) peers Seth J. Rotz

Countries citing papers authored by Marko Kavčič

Since Specialization
Citations

This map shows the geographic impact of Marko Kavčič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Kavčič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Kavčič more than expected).

Fields of papers citing papers by Marko Kavčič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Kavčič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Kavčič. The network helps show where Marko Kavčič may publish in the future.

Co-authorship network of co-authors of Marko Kavčič

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Kavčič. A scholar is included among the top collaborators of Marko Kavčič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Kavčič. Marko Kavčič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tesovnik, Tine, Barbara Jenko Bizjan, Jernej Kovač, et al.. (2024). PAX5 Alterations in a Consecutive Childhood B-Cell Acute Lymphoblastic Leukemia Cohort Treated Using the ALL IC-BFM 2009 Protocol. Cancers. 16(6). 1164–1164. 3 indexed citations
2.
Kavčič, Marko, et al.. (2024). The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia. Radiology and Oncology. 58(1). 133–144. 1 indexed citations
3.
Kavčič, Marko, et al.. (2023). Paediatric Medical Traumatic Stress in Children with Cancer and their Parents: Difference in Stress Levels Due to Illness and Treatment Factors. Journal of Child & Adolescent Trauma. 16(3). 579–587. 3 indexed citations
4.
5.
Jazbec, Janez, et al.. (2020). Centrosomal protein72 rs924607 and vincristine-induced Neuropathy in Pediatric Acute Lymphocytic Leukemia: meta-analysis. Future Science OA. 6(7). FSO582–FSO582. 6 indexed citations
6.
Kavčič, Marko, et al.. (2018). Spectrum of Parvovirus B19 Infection Presentations in Children with Underlying Hemato-oncologic Disorders: A Case Series. Klinische Pädiatrie. 230(6). 330–332. 3 indexed citations
7.
Jazbec, Janez, et al.. (2018). Parvovirus B19-associated Hemophagocytic Lymphohistiocytosis in a Patient With Glucose-6-phosphate Dehydrogenase Deficiency. Journal of Pediatric Hematology/Oncology. 40(8). e550–e552. 3 indexed citations
8.
Vujković, Marijana, Edward F. Attiyeh, Rhonda E. Ries, et al.. (2017). Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children’s Oncology Group report. Blood. 129(23). 3051–3058. 15 indexed citations
9.
Miller, Tamara P., Kelly Getz, Marko Kavčič, et al.. (2016). A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children’s Oncology Group. Leukemia & lymphoma. 57(7). 1567–1574. 12 indexed citations
10.
Vujković, Marijana, Edward F. Attiyeh, Rhonda E. Ries, et al.. (2015). Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology Group. Cancer Genetics. 208(7-8). 408–413. 3 indexed citations
11.
Desai, Ami V., Marko Kavčič, Yuan‐Shung Huang, et al.. (2014). Establishing a high‐risk neuroblastoma cohort using the pediatric health information system database. Pediatric Blood & Cancer. 61(6). 1129–1131. 15 indexed citations
12.
Fisher, Brian T., Julia Shaklee Sammons, Yichen Li, et al.. (2014). Variation in Risk of Hospital-Onset Clostridium difficile Infection Across  -Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia. Journal of the Pediatric Infectious Diseases Society. 3(4). 329–335. 18 indexed citations
13.
Maude, Shannon L., Julie C. Fitzgerald, Brian T. Fisher, et al.. (2013). Outcome of Pediatric Acute Myeloid Leukemia Patients Receiving Intensive Care in the United States. Pediatric Critical Care Medicine. 15(2). 112–120. 40 indexed citations
14.
Fisher, Brian T., Marko Kavčič, Yichen Li, et al.. (2013). Antifungal Prophylaxis Associated With Decreased Induction Mortality Rates and Resources Utilized in Children With New-Onset Acute Myeloid Leukemia. Clinical Infectious Diseases. 58(4). 502–508. 16 indexed citations
15.
Kavčič, Marko, Brian T. Fisher, Yimei Li, et al.. (2013). Induction mortality and resource utilization in children treated for acute myeloid leukemia at free‐standing pediatric hospitals in the United States. Cancer. 119(10). 1916–1923. 33 indexed citations
16.
17.
Kavčič, Marko, Brian T. Fisher, Alix E. Seif, et al.. (2012). Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States. The Journal of Pediatrics. 162(6). 1252–1258.e1. 44 indexed citations
18.
Kavčič, Marko, Brian T. Fisher, Kari Torp, et al.. (2012). Assembly of a cohort of children treated for acute myeloid leukemia at free‐standing children's hospitals in the United States using an administrative database. Pediatric Blood & Cancer. 60(3). 508–511. 34 indexed citations
19.
Walker, Damian, Yimei Li, Yuan‐Shung Huang, et al.. (2012). Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric cancer patients.. Journal of Clinical Oncology. 30(15_suppl). 1504–1504. 1 indexed citations
20.
Grošelj, Urh, et al.. (2006). Abstract 11: Is Therapeutic Hypothermia After Cardiac Arrest Harmful For Diabetic Patients?. Circulation. 114. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seth J. Rotz Breakdown of academic impact, for papers by Kari Torp Breakdown of academic impact, for papers by George R. Buchanan Breakdown of academic impact, for papers by Ülker Koçak Breakdown of academic impact, for papers by Luca Cupelli Breakdown of academic impact, for papers by Makoto Tsujita Breakdown of academic impact, for papers by Hor Ismail Breakdown of academic impact, for papers by Rahul Naithani Breakdown of academic impact, for papers by Domingo del Castillo Breakdown of academic impact, for papers by Gökçen Örgül
Rankless by CCL
2026